Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution

Wong R, Topliss DJ, Bach LA, Hamblin PS, Kalff V, Long F, Stockigt JR

(2009), Intern Med J, 39(3), 156-63

Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B.

Strobel K, Dummer R, Steinert HC, Conzett KB, Schad K, Lago MP, Soyka JD, Veit-Haibach P, Seifert B, Kalff V

(2008), Eur J Nucl Med Mol Imaging, 35(10), 1786-95

Metastatic colorectal cancer to a primary thyroid cancer.

Cherk MH, Moore M, Serpell J, Swain S, Topliss DJ

(2008), World J Surg Oncol, 6, 122

Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma

Cherk MH, Kalff V, Yap KS, Bailey M, Topliss D, Kelly MJ

(2008), Clin Endocrinol, 69(6), 957-62

A prospective reassessment of the utility of the Wells score in identifying pulmonary embolism

Yap KS, Kalff V, Turlakow A, Kelly MJ

(2007), Med J Aust, 187(6), 333-6

S-100B and FDG-PET/CT in therapy response assessment of melanoma patients

Strobel K, Skalsky J, Steinert HC, Dummer R, Hany TF, Bhure U, Seifert B, Pérez Lago M, Joller-Jemelka H, Kalff V

(2007), Dermatology, 215(3), 192-201

Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B

Strobel K, Skalsky J, Kalff V, Baumann K, Seifert B, Joller-Jemelka H, Dummer R, Steinert HC

(2007), Eur J Nucl Med Mol Imaging, 34(9), 1366-75

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease

Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, Ackermann U, Saunder T, Tochon-Danguy H, Jones G, Smith C, O'Keefe G, Masters CL, Rowe CC

(2007), J Nucl Med, 48(4), 547-52

Validation of a new cardiac image fusion software for three-dimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography

Gaemperli O, Schepis T, Kalff V, Namdar M, Valenta I, Stefani L, Desbiolles L, Leschka S, Husmann L, Alkadhi H, Kaufmann PA

(2007), Eur J Nucl Med Mol Imaging, 34(7), 1097-106

Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure

Krum H, Ashton E, Reid C, Kalff V, Rogers J, Amarena J, Singh B, Tonkin A

(2007), J Card Fail, 13(1), 1-7

Evaluation of sympathetic re-innervation in heterotopic cardiac transplants by iodine-123-metaiodobenzylguanidine (I-123-MIBG) imaging

Yap KS, Gould P, Kalff V, Kaye DM, Esmore D, Kelly MJ

(2006), J Heart Lung Transplant, 25(8), 977-80

Focal MIBI uptake is a better indicator of active myeloma than diffuse uptake

Nandurkar D, Kalff V, Turlakow A, Spencer A, Bailey MJ, Kelly MJ

(2006), Eur J Haematol, 76(2), 141-6

Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery

Kalff V, Duong C, Drummond EG, Matthews JP, Hicks RJ

(2006), J Nucl Med, 47(1), 14-22

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

Cebon J; Australasian Gastro-Intestinal Trials Group (AGITG) Ag0001H Investigators

(2006), Br J Cancer, 95(7), 853-61

1 2 3